Edward Carr, CAO of Dianthus Therapeutics DNTH, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $3.6M. The latest trade was on 03/12.

EC

EC

Edward Carr

Chief Accounting Officer

Company

Dianthus Therapeutics DNTH

First filing

24/01/26

Trades

15 trades

Buys / sales

0 / 5

12-month net buying

−$3.6M

Last trade

03/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dianthus TherapeuticsDNTH	Open-market sale10b5-1 plan	03/12	03/13	43,682 sh5 trades	$81.49avg.	$3,559,494.57	−100.0%